Canada markets closed

ASLN Jul 2024 2.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
At close: 03:22PM EDT
Full screen
Previous Close0.0500
Open0.0500
Bid0.0000
Ask0.2000
Strike2.50
Expire Date2024-07-19
Day's Range0.0500 - 0.0500
Contract RangeN/A
Volume20
Open Interest581
  • GlobeNewswire

    ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change

    SAN MATEO, Calif. and SINGAPORE, June 14, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN” or the “Company”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it plans to change the ratio of the American Depositary Shares (“ADSs”) to its ordinary shares, par value $0.01 per share, from one (1) ADS representing twenty-five (25) ordinary shares to one (1) ADS representing tw

  • Zacks

    All You Need to Know About ASLAN Pharmaceuticals (ASLN) Rating Upgrade to Buy

    ASLAN Pharmaceuticals (ASLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Zacks

    Here's Why ASLAN Pharmaceuticals (ASLN) Could be Great Choice for a Bottom Fisher

    ASLAN Pharmaceuticals (ASLN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.